Erratum: Abrogation of signal-dependent activation of the cdk9/cyclin T2a complex in human RD rhabdomyosarcoma cells (Cell Death and Differentiation (2006) vol. 14 10.1038/sj.cdd.4402008);Abrogation of signal-dependent activation of the cdk9/cyclin T2a complex in human RD rhabdomyosarcoma cells [4]

Cell Death and Differentiation

Volumn 14, Issue 1, 2007, Pages 192-195

  Simone, C ^a,b   Giordano, A ^a  

^a Temple University   (United States)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 7; CYCLIN DEPENDENT KINASE 9; LUCIFERASE; MYOD PROTEIN; PROTEIN P53; SYNAPTOPHYSIN;

ADIPOGENESIS; AMINO ACID SEQUENCE; BINDING SITE; CELL CLONE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SUBSTRATE; GENE OVEREXPRESSION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HYPOTHESIS; IMMUNOPRECIPITATION; LETTER; MUSCLE FIBRIL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; TUMOR CELL; UPREGULATION;

EID: 33845505692     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/sj.cdd.4402032     Document Type: Erratum

References (20)

1. Puri PL, Sartorelli V (2000) J. Cell. Physiol. 85: 155-173.
2. Sartorelli V, Puri PL (2001) Front. Biosci. 6: D1024-47.
3. Simone C et al. (2002) Oncogene 21: 4137-4148.
4. Simone C, Giordano A (2001) Front. Biosci. 6: D1073-D1082.
5. Song A et al. (1998) Mol. Cell. Biol. 18: 4994-4999.
6. Kitzmann M et al. (1999) Mol. Cell. Biol. 19: 3167-3176.
7. Tintignac LA et al. (2000) Exp. Cell Res. 259: 300-307.
8. Simone C et al. (2002) Oncogene 21: 4158-4165.
9. Lassar A, Munsterberg A (1994) Curr. Opin. Cell Biol. 6: 432-442.
10. Molkentin JD, Olson EN (1996) Proc. Natl. Acad. Sci. USA 93: 9366-9373.
11. Tintignac LA et al. (2004) Mol. Cell. Biol. 24: 1809-1821.
12. Iankova I et al. (2006) Mol. Endocrinol 20: 1494-1505.
13. Radhakrishnan SK, Gartel AL (2006) Cell Cycle 5: 519-521.
14. Chang SC et al. (2005) Int. J. Oncol. 26: 65-75.
15. Puri PL et al. (2000) Genes Dev. 14: 574-584.
16. Simone C et al. (2004) Nat. Genet 36: 738-743.
17. Giacinti C et al. (2006) J. Cell. Physiol. 206: 807-813.
18. Wu Z et al. (2000) Mol. Cell. Biol. 20: 1809-1821.
19. Sanchez-Prieto R et al. (2000) Cancer Res. 60: 2464-2472.
20. Merlino G, Helman LJ (1999) Oncogene 18: 5340-5348.